Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Impact Biomedicines
is defunct.
Bought by Celgene, Jan 2018, up to $7B
------------------
If you believe any of this information is incorrect, please
let us know
.